Member Info for PM2022

For the deadline

stage 1 with deadlines : DD to be concluded

If it fails markets get notified within the timeframe that has not happened. If it passes it goes to stage 2 which is likely to be to negotiate with all the partners (Val etc) and complete legal work.

Website taken down on 30th calendar day. So i guess they have been on stage 2/3 for the last few weeks.

I cannot see the merger failing. Timelines still remain that Val will get paid this year so guessing merger should complete this week.

A great risk to reward as actually it looks more likely the merger is going to complete not less. Our market cap probably just factors in the 401 deal which was worth zero a few weeks ago and nothing else.

Lots of options for cash given our superb medium/long term value on offer. My guess is that TRX takes a stake at a much higher price giving us cash for a few months for some extra shares.

We are also due a quarterly update so hopefully we should move back above 10p soon. Great risk vs reward imo.

The fact you have come to the rescue proves I have a point.

I doubt you would try and counter me if I was not right. We all know how you operate.

Well at 15p Val is still multiples below where it should be, they make big money we sort out our short term issues and they get moving trying to make 201 happen. That is the worst case situation BOD should be looking at. Best case deal signed as expected this year.

The company is open to serious manipulation by TRX so they should have a stake at a decent price if they keep missing deadlines.

I can see many non holders would not want that but it would be the right thing for the actual people that hold the stock and own the company.

If the merger fails TRX should be forced to buy at least £500k Val shares at no less than 15p to keep exclusivity for 201. They have been responsible for the mess over the last 2 years and causing such a large drop in SP with missed deadlines.

Nothing has changed the deal is still on the deadline was for dd to complete and now this appears to be on track to complete soon as we have not been notified that the merger has failed. Therefore the drop is not justified.

Apart from 201 we have many projects worth multiples of our market cap so I expect anyone selling here to be selling at a large loss only to buy back much higher. Not exactly smart trading.

Not at all. You obviously can't read and understand the article.

Anyway no news is good news here so far. If Valirx felt 201 would not be signed this year they would have told us. My guess is we are awaiting final approvals before the news.

They don’t even burn 2.4 million at the moment and the lab will generate decent revenue. Even 1 million may be enough with lab revenue.

I'll go for Monday to start a huge Christmas rally next week over in the states for EUDA and here as well.

If it was bad surely we would have known and the outcomes would have been known already. Big news often comes on a Monday or Friday afternoon.

So basically you are saying BOD are lying when they say they will get paid when the sublicense is signed this year.

You are someone that was buying 4D from 90p down to 16p before It went bust when most others were selling, the largest holder was even selling and they were burning 55 million a year with no real cash and all you were saying was they had 10 drugs or whatever. Posting your buys on Twitter. An amateur investor if you ask me.

Val would be in touch with TRX and the fact nothing has been done indicates all is good imo.

The time taken indicates the merger is happening imo.

Valirx would have outlined the expectations regarding 201. Payments this year or else and they need 201. So an exciting few days ahead I hope.

As for Porky he has an agenda. We put our money where our mouth is unlike him who has an agenda..

I don't expect the LOI to remain the same. Valirx needs to consult solicitors to get it done but they will be well aware of timings it would all be to avoid a placing in the next 2 years. Obviously the time taken indicates that progress is being made but lots of discussions and agreements are needed.

Who knows what if we get 4/5 million upfront with 61 million milestones. We could gap up to 30 p.

Expecting an update by next week Monday.

I don't think she can answer such a question at the moment until EUDA releases that information themselves.

She may not know everything about the merger and documents it could be Stella who is dealing with that side of things. She might just get updates.

Well if you don't like it then find another stock that you do like.

As for questions why not just email the CEO? Again if you feel the answer she gives relative to the stage of drugs vs market cap is not good enough then look elsewhere. Nobody is forcing you to invest so I just think you got an agenda being on this board pretending to have saved money.

Your could have purchased at 3 p a few years back and sold at 74 p. Well do the maths on that will you. In fact it has had significant rises and falls a few times.

Surely Inophea is generating some decent revenue now.

Our cash burn was under 2 million if you take out costs associated with the asset purchase. With lab revenue it is hopefully about 1.5 million and hopefully will decrease much further.

The 201 money will come in handy with huge upside to about 100 million with a few decent outcomes. People often invest in AIM companies that burn 2/3 times more cash than the market cap.

Valirx are undervalued and the finances are fairly good. A good buy at these prices with 201 news to come in the coming days. We have been to 60/70 p twice with smaller 201 news.

Even as a trade 15 p would be 50% not a bad price to buy imo.

Expecting more news soon and 201 to come.

No SP was about 65 p back in Nov 2021. That was without CLX, lab, Imogen, 401 deal and funding for 201.

As for a placing the last two were at 10 p and 11 p. The company has since had CLX, Lab , Imogen asset and 401 deal and 201 is due to complete this year.

If the BOD really believes they are adding value then we have nothing to worry about. 201 news is likely to come from today to Monday so time will tell.

201 deal expected to complete this year. It all looks positive from EUDA and TRX can't see it failing now after all this work.

Val has enough cash until March based on my logic so all is good. Gap up could be 25/30 p with that news.

Also remember circumstances have changed over the last 2 years and who is to say Val will not get 3,4, 5 million upfront payments. We don't know but if TRX has raised big money as widely speculated then watch out.

201 deal expected to complete this year. It all looks positive from EUDA and TRX can't see it failing now after all this work.

Val has enough cash until March based on my logic so all is good. Gap up could be 25/30 p with that news.

Also remember circumstances have changed over the last 2 years and who is to say Val will not get 3,4, 5 million upfront payments. We don't know but if TRX has raised big money as widely speculated then watch out.

Suzy owns 40% of 401 she knows what she is doing with it.

The 401 deal is a bonus and a big one as it was never expected to get done. Counts as a phase 3 drug as only one trial is needed.

If they agreed to pay 16 million then expected royalty payments are likely to also be high.

That is based on your false and misleading figures.

Official figures are in the broker report but that does not include cut back during November and December which would be expected. They would not be spending 180 k a month in November and December, maybe £70 k/£80 k then you got the 180 k in Jan plus lab revenue. It takes us to March if they were to just pay for rent and wages.

Valirx does not pay 180 k in wages per month more like 40/50 k. As long as 201 gets done soon then all good plenty of time.